Company / Depreciation & Amortization
Bioventus Inc. Depreciation & Amortization History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$47.0M
FY2025
5-year range
$30.3M / $55.4M
FY2021-FY2025
Trend
-5.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 5 years, ranging from $30M in FY2021 to $55M in FY2022.
Based on SEC 10-K filings.
$47M in FY2025 with a 3-year CAGR of -5.3%.
Increased from $35M to $47M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -5.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -5.3%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 5.1% year-over-year.
- Peak depreciation & amortization was recorded in FY2022.
- Lowest depreciation & amortization in the period was in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $47.0M | -5.1% |
| FY2024 | $49.6M | +42.1% |
| FY2023 | $34.9M | -37.0% |
| FY2022 | $55.4M | +82.7% |
| FY2021 | $30.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026